 |
Pathways
Underlying Disorders
Mouse
study may shed light on face and skull abnormalities. |
Abnormalities
of the face and skull rank among the most common birth defects in humans.
Understanding such complex human disorders requires a systems biology
approach, according to Cymbeline Culiat, a molecular geneticist in
ORNL's Life Sciences Division. She is taking this approach as she investigates
a series of eight mutant mouse strains that could serve as animal models
for deciphering the complex molecular interactions underlying skull
development.
|

ORNL mice and rabbits (studied elsewhere and shown above) are potential models for
children suffering from a condition wherein skull bones grow very fast and fuse
prematurely, causing facial abnormalities and preventing further brain growth.
|
"We found that these eight mutations occurred in the same gene and that this
gene codes for a novel cell-signaling protein critical to the development of
bones in both the skull and spine," Culiat says. "This collection of mutant mice
carrying different changes in the same protein gives us an excellent opportunity
to understand that particular protein's various functions."
In the mutations
being studied by her group, when one part of the protein is affected
by a mutation, a mouse may be born with a deformed skull and face but
a normal spine. If another portion of the protein is affected, severe
defects in both the skull and spine occur. In this gene's most severe
mutation (designated 102DSJ), the amount of protein being made is greatly
reduced. The mice with this mutation exhibit extreme alterations in
spine curvature and skull anomalies.
"Our mice
are potential models for children suffering from craniosynostosis (CS),
a condition wherein skull bones grow very fast and fuse prematurely,
preventing further brain growth," she says. "Children with CS undergo
major skull reconstruction at an early age and can suffer from mental
retardation, visual and hearing impairment, and skeletal defects of
the limbs and spine.
"Some children
with CS manifest the same type of spinal defect observed in our mutant
mice and some do not," Culiat continues. "If we can figure out why
and how the mutant protein in our mouse models affects both the developing
skull and spine, we will better understand this complex human disorder."
The availability
of mouse and human genome sequences, rapid advances in technologies
for detecting and measuring changes in gene expression, and computational
tools for analyzing vast amounts of data are allowing Culiat and her
associates to seek answers to systems biology types of questions: Which
groups of genes interact and how do proteins interact to ultimately
control the development of specific biological structures or perform
certain functions? When a mutation occurs in a key gene in a pathway,
how does the resulting perturbation in the pathway's other genes ultimately
lead to a disease or abnormality?
Culiat established
a collaboration with Mark Shannon of Applied Biosystems-Celera, which
has developed sophisticated gene expression technology. Shannon wanted
to test his company's technology on a large scale, to determine how
useful it is for studying biological pathways in a whole organism—such
as a mutant mouse.
Using bioinformatics
data, the collaborators initially studied 300 genes in normal mice,
as well as in mutant mice carrying the most severe mutation (102DSJ).
The genes are involved in bone, cartilage, and brain development and
in cell proliferation and differentiation. The researchers also assayed
the expression of genes coding for proteins that could potentially
interact with the mutant protein, based on knowledge of the predicted
functional domains.
Shannon's
lab performed thousands of very sensitive assays of RNA samples extracted
from mouse embryos. The results showed that 33 out of 300 genes were
significantly perturbed and that the majority of the genes exhibited
reduced expression in all mice with the 102DSJ mutation.
"Most of
the affected genes are involved in biological processes that are critical
for the maturation of precursor bone cells," Culiat says. "Some of
the genes were perturbed only in the head but not in the body, while
others showed alteration in expression in the body but not in the head."
Culiat hopes
future research on protein interactions will shed light on the inherent
complexity of biological processes underlying such genetic disorders.

Computer visualization of an E. coli bacterial protein
using Visual Molecular Dynamics software.
|
Microbes
on a Mission
The Department
of Energy seeks to understand the diverse range of biochemical pathways
that enable single celled organisms to survive under extreme conditions—high
temperature, high radiation, and high concentrations of toxic chemicals.
DOE is interested in harnessing the genes of these microbes, whose
capabilities could help DOE meet its missions in environmental bioremediation,
carbon sequestration to slow climate change, and energy production.
ORNL researchers and their collaborators are studying these microbes
as part of DOE's Microbial Genome Program and Genomics: GTL Program.
Multitalented
bacteria of interest to DOE include Deinococcus radiodurans,
which can withstand high doses of radiation because these cells efficiently
repair radiation damage. Like Shewanella oneidensi, which
is also studied at ORNL, these bacteria reduce certain metals—that
is, they donate electrons to toxic metals, like chromium and uranium,
so they can extract energy from carbon. When these metals accept the
electrons, they often are converted from a soluble to an insoluble
state, possibly enabling bioremediation.
Questions
that drive some ORNL research include the following: How will these
bacteria respond to the stress of a soil or groundwater environment
loaded with toxic and radioactive metals? Will some bacterial cells
convert radioactive uranium in storage ponds from a soluble to an insoluble
form so that this toxic metal sinks into the sediments or stays put
in soil instead of dissolving in water that may flow off-site? Can
a microbe like Deinococcus radiodurans be "designed" so that
more of its genes focus on remediating sites with mixed wastes—combinations
of radioactive materials and toxic metals? Can a uranium-contaminated
site be populated with Shewanella oneidensi or some other
bacteria "trained" to remove uranium from groundwater and moist soil,
saving DOE billions of dollars in toxic waste cleanup activities?
Certain
bacteria in the ocean and on land take up carbon dioxide from the atmosphere
and perform photosynthesis. Can genes from these bacteria be harnessed
to help DOE halt the buildup of atmospheric carbon dioxide from energy
production? Can the poplar tree be designed to grow faster and take
up more atmospheric carbon dioxide that will be stored in its branches
and roots? Can systems biology find ways to ensure that more carbon
from decaying roots stays locked up in soil rather than being released
back into the atmosphere?
DOE is
also interested in microbes that produce clean fuels, such as methane,
methanol, and hydrogen. ORNL researchers and their collaborators are
focusing on Rhodopseudomonas palustris as a potential energy
source. Can it be grown in a certain way or can its genes be harnessed
to produce hydrogen efficiently? Can enough hydrogen be produced biologically
for use in power-producing fuel cells for cars and buildings in the
envisioned hydrogen economy?
Researchers
in ORNL's Environmental Sciences Division are addressing these and
other key scientific questions about the microbial community: What
is the genetic diversity of microbial communities? How do environmental
disturbances, such as contaminants, affect the structure, functional
stability, and adaptive capacities of microbial communities? Can the
diversity and metabolic capabilities of a microbial community be manipulated
to achieve desired functions, such as remediation of mixed-waste contaminants?
To understand
how a cell works, researchers must understand how protein complexes
do the work of the cell. Questions that ORNL biologists are asking
and hope to address using systems biology include the following: Why
does a certain protein complex behave the way it does? How far can
a protein complex be twisted so that it does something a little different
better, cheaper, and faster than it did before? Will the protein complex
meet our needs yet still survive? If a certain genetic part of a mutant E.
coli bacterium is knocked out, will the bacterium suddenly produce
more succinic acid for making useful products? If bacteria capable
of anaerobic digestion are grown on a particular feedstock, will large
amounts of methane be produced all the time, even when the feedstock
is changed? To save time and money, could a biology experiment be simulated
on a computer and confirmed in the laboratory?
These and
other questions are driving biological research at ORNL and fueling
the revolution in post-genome biology.
|